FDA Inspection 1187283 — American Laboratories Pharma, LLC

American Laboratories Pharma, LLC — FEI 1920841

The FDA completed an inspection of American Laboratories Pharma, LLC on October 3, 2022 in Omaha, NE. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 3, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Omaha, NE (United States)